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Abstract The calcium-dependent i teraction between calmodulin (CaM) and the synthetic oligopeptide of a predicted CaM-binding region of human 
calcineurin A-2 was analysed with an automated surface plasmon resonance biosensor, BIAcore. The oligopeptide was immobilized to a biosensor 
chip via the amino-terminal cysteine residue by a thioldisulphide exchange method. The biosensor chip was regenerated by an EGTA-containing 
buffer after each analysis. Kinetics experiments howed that CaM bound with a high affinity to the oligopeptide in a Car’-dependent manner. The 
estimated rate constants of association (k,,) and dissociation (k& were 2.3 x lo5 M-’ .s-’ and 3.9 x 10-r s-‘, respectively. The ratio of k,,,,lk,,,, 
1.7 x 10-r M, was in good agreement with the dissociation constant (Kd) of 2.4 x 10m8 M determined from the equilibrium phase. 
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1. Introduction 
Calmodulin (CaM) is a ubiquitous Ca*‘-binding protein in- 
volved in a variety of Ca*‘-dependent signaling pathways in 
eukaryotic cells, and regulates the activities of a large number 
of proteins including protein kinases, phosphatases, and cal- 
cium pumps as well as those involved in motility [1,2]. CaM 
with 148 residues containing four helix-loop-helix (EF-hand) 
Ca*‘-binding structures is known to recognize a short segment 
of 20-30 residues in the target proteins [3,4]. There is no obvi- 
ous sequence homology among the CaM-binding regions, but 
they have propensity to form basic amphiphilic a-helical struc- 
tures [3]. Recently, some three-dimensional structures of com- 
plexes between CaM and CaM-binding oligopeptides have 
been elucidated [S-7]. Binding affinities between CaM and 
these target oligopeptides have been analysed by several meth- 
ods including competition assays using myosin light chain ki- 
nase, circular dichroism specroscopy, electrophoretic mobility 
shift assay and fluorometric methods [S]. The fluorometric 
methods involve either measuring changes of intrinsic trypto- 
phan fluorescence of the peptides upon binding to CaM which 
contains no tryptophan residue [9] or measuring the fluores- 
cence change of dansylated CaM with unlabeled peptides [lo]. 
Rate constants of association and dissociation, however, could 
not be easily determined by these conventional methods. 
The recently developed BIAcore biosensor instrument allows 
real-time analyses of biospecific interactions by detecting sur- 
face plasmon resonance (SPR) signals, and is applicable to 
various studies on structure-function relationships of macro- 
molecules of interest [I 11. Employing the BIAcore system, we 
demonstrate for the first time the Ca*‘-dependent interaction 
between CaM and the synthetic oligopeptide of the previously 
predicted CaM-binding region in calcineurin, a Ca*‘/CaM-de- 
pendent protein phosphatase [ 12,131. 
*Corresponding author. Fax: (81) (75) 751-3998. 
Abbreviations: EDC, N-ethyl-N-(dimethylaminopropyl)carbodiimide; 
NHS, N-hydroxysuccinimide; CaM, calmodulin; SPR, surface plasmon 
resonance; PDEA, 2-(2-pyridinyldithio)ethaneamine hydrochloride. 
2. Material and methods 
2.1. Materials 
A 25-residue oligopeptide containing the predicted CaM-binding re- 
gion in human calcineurin A-2 [13,14] with a cysteine residue added at 
its N-terminus, designated as CNApep25, was custom-synthesized by 
Sawaday Technology Inc. (Tokyo, Japan). CaM purified from bovine 
brain was obtained from Sigma Chemical Co. (St. Louis, USA). A 
sensor chip CM5, a coupling reagent kit and a 10% solution of Tween 
20 (Surfactant P20) were from Pharmacia Biosensor AB (Uppsala, 
Sweden). The other reagent grade chemicals were purchased from 
Nacalai Tesque (Kyoto, Japan) or Wako Pure Chemicals (Osaka, 
Japan). 
2.2. Surface plasmon resonance measurements 
Real-time analysis of Ca”-dependent interaction between CaM and 
the calcineurin oligopeptide was performed with a BIAcore instrument 
(Pharmacia Biosensor AB). The principle and application of the system 
employing the method of surface plasmon resonance (SPR) detection 
was described by Karlsson et al. [1 11. Coupling of oligopeptide CNA- 
pep25 to the sensor chip CM5 was performed by the ligand thiol 
method as described [15]. A continuous flow of HBS buffer (10 mM 
HEPES, pH 7.4, 0.15 M NaCI, 3.4 mM EDTA, 0.005% Tween 20) 
passing over the sensor surface was maintained at 5 @/min. The car- 
boxylated dextran matrix was activated by injection of 10 ~1 of a 
solution containing 0.2 M EDC and 0.05 M NHS, and modified by 
injection of 2Op1 of 80 mM PDEA in 0.1 M borate buffer, pH 8.5. Next, 
35 ~1 of 50 &ml CNApep25 solution in 50 mM formate, pH 4.0, was 
injected and the oligopeptide was immobilized via thiol-disulphide ex- 
change reaction. Finally, a 20 ~1 of 50 mM cysteine-1 M NaCl was 
injected to deactivate xcess reactive groups and to wash out unbound 
oligopeptides. 
The SPR measurements for the binding of CaM to the immobilized 
CNApep25 were performed at 2 @/ml in Buffer F (20 mM Tris-HCI, 
pH 7.5, 150 mM NaCI, 1 mM EGTA, 1.5 mM CaCl,, 0.005% Tween 
20). The sensor chip was regenerated after each analysis cycle by inject- 
ing 6~1 of Buffer F without CaCl,, and then initialized with continuous 
flow of Buffer F. 
3. Results and discussion 
Calcineurin, a Ca*‘/CaM-dependent serinelthreonine-spe- 
cific protein phosphatase, isa heterodimer of a 61 kDa catalytic 
subunit (calcineurin A) and a 19 kDa regulatory subunit (cal- 
cineurin B) [ 121. This phosphatase isnow known to be inhibited 
by immunophillins, the binding proteins of immunosuppressive 
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A concentrations of CaM as shown in the association phase 
(arrow a). Washing the sensor chip with the running buffer 
caused gradual decrease of the SPR signals, indicating a time- 
dependent dissociation of CaM from the immobilized CNA- 
pep25 (dissociation phase, arrow b). The sensor chip was easily 
stripped of bound CaM by the buffer without Ca*’ as indicated 
by the drop of the SPR signal to the base line level (regeneration 
phase, arrow c). 
Human 
calcineurin A-2 
“” 
Predicted &M-binding 
region GSAAkKEllRNKlRAlGKMAR”Fk”LREESESV 
Synthetic oligopeptide 
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Fig. 1. Immobilization of the synthetic oligopeptide of calcineurin A. 
(A) A sequence of the 25-residue ohgopeptide used in the present study. 
The oligopeptide, designated as CNApep25, corresponds to the pre- 
dicted CaM-binding region in human calcineurin A-2 and contains an 
added cysteine at the N-terminus. (B) A sensorgram of immobilization 
of oligopeptide CNApep25 by the thiol ligand method. The bars indi- 
cated by a, b, c and d refer to the stages in the immobilization proce- 
dure: a, activation of sensor chip by NHS/EDC; b, modification by 
PDEA; c, immobilization of ligand (CNApep25); d, deactivation and 
washing with 50 mM cysteine-1 M NaCl. dR indicates the amount of 
immobilized ligand (880 RU). 
drugs cyclosporin A and FK506 [16]. CaM binds to calcineurin 
A, and its potential binding site was predicted by Kincaid et al. 
[ 131 by comparing the sequence with those of the known CaM- 
binding regions in other proteins, but direct binding of CaM 
to such a sequence in calcineurin A has not been reported. Fig. 
1A shows the amino acid sequence of a potential CaM-binding 
synthetic oligopeptide CNApep25, corresponding to residues 
400-423 of human calcineurin A-2 [14] with an additional cys- 
teine residue at the N-terminus. The oligopeptide was immobi- 
lized to a BIAcore sensor chip using a thiol coupling reagent 
PDEA as shown in Fig. 1B. Since 1000 RU is equivalent to a 
change in surface concentration of about 1 ng/mm’ for most 
macromolecules [15], the amount of the immobilized ligand was 
estimated to be 880 pg/mm* from the increased resonance signal 
(AR) of 880 RU. 
CaM solutions of various concentration were passed over the 
CNApep25Gmmobilized biosensor chip in the presence of Ca*‘, 
where the amounts of bound CaM were detected as changes of 
SPR signals, and expressed as relative response. Fig. 2A dis- 
plays an example of overlaid sensorgrams using five different 
concentrations of CaM (12.5-500 nM). The rates of association 
and values of relative response at equilibrium depended on the 
Rates of association (dRldt) using various concentrations of 
CaM were analysed with kinetics evaluation software installed 
in the BIAcore. The plots of dR/dt vs. relative response gave 
linear relationships (Fig. 3A). The negative values of the slopes 
(apparent association rate constant, kapp, at each concentration 
of CaM) were re-plotted against CaM concentration (Fig. 3B). 
The association rate constant (k,,,) was obtained from the 
slope: k,, = 2.3 x 10 ’ M-’ .s-‘. The plot of steady state binding 
levels (Reqr elative response at equilibrium) vs. CaM concentra- 
tions gave a saturation curve, indicating a specific interaction 
of CaM with DNApep25 (Fig. 4). The dissociation constant 
(&) determined by Scatchard plot (inset) was 2.4x lo-* M. 
R,,, (maximum binding capacity) was calculated to be 1800 
RU, or 1800 pg/mm*. 
Assuming a one-to-one stoichiometric interaction between 
CaM and CNApep25, the oligopeptide accessible to CaM was 
calculated to be about 37% based on their molecular weights 
and observed response (immobilized oligopeptide: 0.3 pmol/ 
mm*, CNApep25, M, = 2929; maximum CaM-binding: 0.11 
pmollmm’, CaM, M, = 16,680). Thus, CaM could not bind to 
about 63% of the immobilized CNApep25 molecules which 
might have been buried far inside the dextran matrix or posi- 
tioned too close one another to be accessible to the large mol- 
ecule. 
For the dissociation phase analysis, the effect of re-binding 
of released CaM to the immobilized CNApep25 was examined. 
At the end of association, 2 PM CNApep25 solution was in- 
jected to compete for CaM-binding with the immobilized oli- 
gopeptide. As shown in Fig. 5A, this procedure accelerated an 
apparent dissociation rate, suggesting a considerable contribu- 
tion of re-binding . Thus, the dissociation rate constant was 
a 
00 
Time [s] 
Fig. 2. Representative overlaid sensorgrams illustrating the real-time 
binding of CaM at various concentrations (25,50,100,200 and 500 nM, 
from bottom to top) to the oligopeptide CNApep25 immobilized on the 
biosensor chip. Analysis was performed with Buffer F (20 mM Tris- 
HCl, pH 7.5, 150 mM NaCl, 1 mM EGTA, 1.5 mM CaCl,, 0.005% 
Tween 20). Arrows indicate phases of (a) association, (b) dissociation 
and (c) regeneration. Regeneration was performed by washing the sen- 
sor chip with Buffer F without Cal’. 
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dissociating components (Fig. 5B). First, the conformation of 
the immobilized oligopeptide may be heterogeneous depending 
on the site of the matrix of the sensor chip. The oligopeptide 
CNApep25 is very basic (calculated isoelectric point, 
p1 = 12.35) and the structure should be significantly affected 
electrostatically by the surrounding acidic charges of the car- 
boxylated dextran matrix. Second, isomerization may occur in 
the complex between CaM and CNApep25 from an intermedi- 
ate form (fast dissociation) to a tight form (slow dissociation) 
during the association phase. Third, some of CaM molecules 
used in the present study may be partly denatured, and the 
defective protein may have a lower affinity. Considering the 
effect of re-binding in kinetics evaluation, further studies are 
required to pursue the cause of the biphasic nature of the 
dissociation 
200 300 400 500 
CaM concentration [nM] 
Fig. 3. Determination of the association rate constant. A, plots of 
association rates (dZUdt) vs. relative response by analysis of the associ- 
ation phase in Fig. 2. Apparent first-order rate constants (kapp) were 
obtained from the slopes according to equation dR/dt = 
k,,CR,,, -k,,,R, where R, binding value expressed as relative response; 
C, concentration of sample; t, time; k,,,, association rate constant. 
(B) A plot of k,,, vs. CaM concentration. The slope gave a value of k,, 
from the equation kapp = k,,,C+k disr where kdlss is a dissociation rate 
constant. k,, = 2.3 x 10’ M-’ .s-‘. 
Using ‘251-labeled CaM, Hubbard and Klee [17] reported 
kinetics of CaM-binding to purified calcineurin which was im- 
mobilized on nitrocellulose membrane filters. The reported dis- 
sociation constant (&) determined by equilibrium binding 
analyses was 1.6 x lo-* M, which agrees with our data 
(K,, = 2.4 x lo-* M, Fig. 4). Rate constants, however, were 20- 
40 times different (in the present study: k,,, = 2.3 x lo5 M-l. s-‘, 
k&slow) = 3.9 x 10m3 s-‘; reported: k,, = 8.9 x 103M-’ .s-‘, 
kdiss = 8.5 x 1O-5 s-l). Although the basis of discrepancy is not 
clear, the greater association rate as revealed in the present 
study meets better the physiological demand that CaM binds 
to the target protein more rapidly in response to an increase of 
intracellular Ca*’ (t,,, at 100 nM CaM: 30 s in this study; 13 min 
in their study) . 
Kinetic analyses by the automated SPR biosensor system are 
fast and simple, and the system should be useful to analyse 
interactions between CaM or other Ca”-binding proteins and 
their target proteins with high molecular weight since the bio- 
sensor chip is easily regenerated under a mild condition with 
a Ca*‘-chelating reagent. 
determined by analysis of the dissociation phase in the presence 
of free CNApep25. The first-order reaction plot revealed two 
components with different dissociation rates (Fig. 5B). The 
calculated dissociation rate constant (kais,) of the major slower 
component (59.7%, designated R,) and the minor faster compo- 
nent (40.3%, designated RJ was 3.9 x 10m3 s-’ and 2.1 x 10-2s-‘, 
respectively. There is a possibility, however, that the accelera- 
tion of the apparent dissociation rate of the complex by addi- 
tion of free CNApep25 was caused by interaction of the oli- 
gopeptide with the pre-formed complex at any second binding 
site in CaM, and not by blocking the re-binding of liberated 
CaM to the immobilized CNApep25. The analysis of dissocia- 
tion phase in the absence of CNApep25 gave a kdiss value 
smaller than 10V3 s-l; an accurate constant could not be ob- 
tained due to the significant residual binding (Fig. 5A, - CNA- 
pe~25). 
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The ratio of the obtained dissociation rate constant 
(k,,,(slow) = 3.9 x 1O-3 s-‘, Fig. 5B) and the association rate 
constant (k,, = 2.3 x lo5 M-’ .s-‘, Fig. 3B) was calculated to be 
1.7 x lo-’ M. This value was in good agreement with the disso- 
ciation constant (K,) of 2.4 x lo-* M determined from the equi- 
librium phase by Scatchard plot analysis (Fig. 4). There are 
several possible reasons for the presence of the fast and slow 
Fig. 4. Scatchard plot analysis for determination of the dissociation 
constant. CaM concentrations ranged from 12.5 nM to 500 nM, and 
data similar to those for Fig. 2 were recorded. Longer injection times 
were used for concentrations below 50 nM to ensure that steady state 
(equilibrium) was reached. Relative response xpressed as steady state 
binding values (R,) and CaM concentrations are plotted as indicated 
(0). (Inset) Scatchard plot. The reciprocal of the slope gave a value of 
the dissociation constant (Kd) of 2.4 x lo-’ M from the following equa- 
tion: R,IC = R,,,IK ,-RJK,. R_, steady state binding value; C, CaM 
concentration; R,,,, maximum binding capacity of the immobilized 
peptide. 
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Fig. 5. Determination of dissociation rate constant. (A) Sensorgrams 
illustrating dissociaton of CaM from the immobilized CNApep25. As- 
sociation start point is indicated by arrow a. At the end of association, 
indicated by arrow b, a 30 ~1 solution of either Buffer F (-CNApep25) 
or 2 PM CNApep25 in Buffer F (+CNApep25) was injected. (B) First- 
order reaction plot of dissociation in the presence of the oligopeptide. 
A value of 90 RU was subtracted as base-line response (undissociable 
component and effect of the CNApep25 solution on SPR response). 
The dissociation rate constant (kdlsr) for the slower dissociation compo- 
nent (R,) was obtained from the slope of the linear line fitting well to 
the plots (0) in the later phase. The relative amount of the fast dissoci- 
ation component (RJ in the earlier dissociation phase was calculated 
by subtracting the theoretical amount of slower dissociation component 
(R,) from the observed response (o), and was re-plotted in the semi- 
logarithmic scale (A). The calculated rate constants are: 
k,,,,(slow) = 3.9 x lo-’ s-‘; k&fast) = 2.1 x IO-* ss’. 
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